If youre a typical user, you dont need to overthink this: popularity reflects accessibility and alignment with lifestyle goals, not breakthrough efficacy
89-LB: the effect of GIP on plasma glucose in a setting of prandial insulin overdose and physical activity after meal intake in patients with type 1 diabetes
Listed effects of GLP-1 include: 1) reduced glucagon secretion from the liver (thereby slowing down the release of glucose, or blood sugar, into the bloodstream during periods of fasting or reduced food intake), 2) increased insulin production, 3) decreased appetite, and 4) decreased intestinal motility (causing food to move slower through the digestive system, thereby further improving blood sugar and reducing appetite)
25-OHC treatment significantly inhibited sterol regulatory element-binding protein (SREBP) expression in IMS32 Xuewang cells, downregulated GXP4 and stearoyl-CoA desaturase 1 (SCD1), and upregulated PTGS2, thereby increasing intracellular ROS levels and promoting ferroptosis
Ipamorelin acts on the distinct GHS-R1a receptor, amplifying the GH release signal through a separate intracellular pathway involving phospholipase C and protein kinase C
Too much signal and you waste money without additional benefit, the response curve plateaus rather than climbing indefinitely